The human gut microbiome in health and disease: time for a new chapter?
Infection and Immunity · 12.11.2024 · 92 (11)
DOI: 10.1128/iai.00302-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Immunity, erschienen am 12.11.2024. Verfasst von Jee-Yon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, School of Medicine, University of California Davis, Davis, California, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Kenneth Rainin Foundation (KRF).
Abstract (Originalsprache)
The gut microbiome, composed of the colonic microbiota and their host environment, is important for many aspects of human health. A gut microbiome imbalance (gut dysbiosis) is associated with major causes of human morbidity and mortality. Despite the central part our gut microbiome plays in health and disease, mechanisms that maintain homeostasis and properties that demarcate dysbiosis remain largely undefined. Here we discuss that sorting taxa into meaningful ecological units reveals that the availability of respiratory electron acceptors, such as oxygen, in the host environment has a dominant influence on gut microbiome health. During homeostasis, host functions that limit the diffusion of oxygen into the colonic lumen shelter a microbial community dominated by primary fermenters from atmospheric oxygen. In turn, primary fermenters break down unabsorbed nutrients into fermentation products that support host nutrition. This symbiotic relationship is disrupted when host functions that limit the luminal availability of host-derived electron acceptors become weakened. The resulting changes in the host environment drive alterations in the microbiota composition, which feature an elevated abundance of facultatively anaerobic microbes. Thus, the part of the gut microbiome that becomes imbalanced during dysbiosis is the host environment, whereas changes in the microbiota composition are secondary to this underlying cause. This shift in our understanding of dysbiosis provides a novel starting point for therapeutic strategies to restore microbiome health. Such strategies can either target the microbes through metabolism-based editing or strengthen the host functions that control their environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, School of Medicine, University of California Davis, Davis, California, USA.
- Department of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California Davis, Sacramento, California, USA.
- Department of Pathology Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
ORCID-Profile: Andreas J Bäumler
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Kenneth Rainin Foundation (KRF)
- HHS | National Institutes of Health (NIH)
- NIDDK NIH HHS
Zitieren
APA
Lee, J. Y., Bays, D. J., Savage, H. P., & Bäumler, A. J. (2024). The human gut microbiome in health and disease: time for a new chapter?. Infection and Immunity, 92(11). https://doi.org/10.1128/iai.00302-24
Vancouver
Lee JY, Bays DJ, Savage HP, Bäumler AJ. The human gut microbiome in health and disease: time for a new chapter?. Infection and Immunity. 2024;92(11). doi:10.1128/iai.00302-24
BibTeX
@article{Lee2024,
author = {Lee, Jee-Yon and Bays, Derek J and Savage, Hannah P and Bäumler, Andreas J},
title = {The human gut microbiome in health and disease: time for a new chapter?},
journal = {Infection and Immunity},
year = {2024},
volume = {92},
number = {11},
doi = {10.1128/iai.00302-24}
}
EUVIMED